Red yeast rice and berberine in the treatment of dyslipidemia:what is the evidence?

Authors

  • Catarina Borges Médica Interna de Medicina Geral e Familiar. Unidade de Saúde Familiar Brás-Oleiro, ACeS de Gondomar
  • Sara China Médica Interna de Medicina Geral e Familiar. Unidade de Saúde Familiar Brás-Oleiro, ACeS de Gondomar
  • Sofia Carrapa Médica Interna de Medicina Geral e Familiar. Unidade de Saúde Familiar Brás-Oleiro, ACeS de Gondomar
  • Vânia Teixeira Médica Interna de Medicina Geral e Familiar. Unidade de Saúde Familiar São Pedro da Cova, ACeS de Gondomar

DOI:

https://doi.org/10.32385/rpmgf.v32i1.11688

Keywords:

Cholesterol-LDL, Triglycerides, Red Yeast Rice, Berberine.

Abstract

Aim: To determine if red yeast rice (RYR) and berberine (BBR) are effective in lowering serum levels of LDL-cholesterol (LDL-C) and triglycerides (TG). Data sources: PubMed and databases of evidence-based medicine. Review methods: Guidelines, meta-analyses (MA), systematic reviews (SR), randomized controlled trials (RCT) and observational studies in English, Portuguese and Spanish were searched, using the MeSH terms (cholesterol, LDL, triglycerides, red yeast rice and berberine). Articles published between January of 2003 and January of 2014, including patients aged 18 years old and older without familial dyslipidemia were selected. The level of evidence (LE) and the strength of recommendation (SR) were assessed using the Strength of Recommendation Taxonomy (SORT) scale from the American Academy of Family Physicians. Results: Of the 34 articles found, 10 met the inclusion criteria. One MA, two SR, four RCT and one retrospective observational study described the effectiveness of RYR for the reduction of LDL-C levels (LE 3). Triglycerides were also effectively decreased by RYR in the MA, in one of the SR and in the RCT (LE 3). The MA and SR that analysed BBR showed its benefit in reducing LDL-C and TG (LE 3). The association of both substances, evaluated in a RCT, was also effective in lowering the levels of LDL-C. Conclusions: The available evidence regarding the reduction of LDL-C and TG levels with administration of RYR and/ or BBR was considered limited (SR C). Thus, before recommending these substances in the treatment of dyslipidemia, more studies of higher quality are needed to demonstrate their beneficial effects and safety. Better control in their production and marketing is also required.

Downloads

Download data is not yet available.

Downloads

Published

2016-02-01

Issue

Vol. 32 No. 1 (2016): Revista Portuguesa de Medicina Geral e Familiar

Section

Reviews

License

The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.

The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.

 

How to Cite

Red yeast rice and berberine in the treatment of dyslipidemia:what is the evidence?. (2016). Portuguese Journal of Family Medicine and General Practice, 32(1), 38-46. https://doi.org/10.32385/rpmgf.v32i1.11688